header image

Publications

Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer
Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer. J Biol Chem. 285: 11786-117892.
February 27, 2010
DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target
DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res. 70: 1766-1772.
February 11, 2010
MicroRNA expression changes in the XFE progeroid syndrome in mice caused by depletion of ERCC1-XPF, a nuclease required for several DNA repair pathways
February 1, 2010
Y Reddy, LJ Niedernhofer, SA Khan
The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways
The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways. J Biol Chem. 286: 3705-3712.
November 27, 2009
Gene therapy for muscular dystrophy reaches human clinical trial
Gene therapy for muscular dystrophy reaches human clinical trial. Ann Neurol. 66: 267-270.
October 3, 2009
Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax
Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax. Neoplasia. 11: 1036-1041.
October 2, 2009
Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers
Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol. 297: C440-450.
June 19, 2009
The companions: regulatory T cells and gene therapy
The companions: regulatory T cells and gene therapy. Immunology. 127: 1-7.
April 17, 2009
PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation
PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood. 113: 4370-4380.
January 10, 2009
Sinorhizobium meliloti, a bacterium lacking the autoinducer-2 (AI-2) synthase, responds to AI-2 supplied by other bacteria
Sinorhizobium meliloti, a bacterium lacking the autoinducer-2 (AI-2) synthase, responds to AI-2 supplied by other bacteria. Mol Microbiol. 70: 1223-1235.
November 8, 2008